James P. McGettigan

2.7k total citations
46 papers, 2.2k citations indexed

About

James P. McGettigan is a scholar working on Virology, Epidemiology and Infectious Diseases. According to data from OpenAlex, James P. McGettigan has authored 46 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Virology, 29 papers in Epidemiology and 27 papers in Infectious Diseases. Recurrent topics in James P. McGettigan's work include Rabies epidemiology and control (36 papers), Viral Infections and Outbreaks Research (26 papers) and Virology and Viral Diseases (25 papers). James P. McGettigan is often cited by papers focused on Rabies epidemiology and control (36 papers), Viral Infections and Outbreaks Research (26 papers) and Virology and Viral Diseases (25 papers). James P. McGettigan collaborates with scholars based in United States, France and Poland. James P. McGettigan's co-authors include Matthias J. Schnell, Bernhard Dietzschold, Amy B. Papaneri, H. Foley, Roger J. Pomerantz, Christoph Wirblich, Catherine A. Siler, Philip M. McKenna, Milosz Faber and Ronald N. Harty and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Nature Reviews Microbiology.

In The Last Decade

James P. McGettigan

46 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
James P. McGettigan United States	28	1.4k	990	987	392	363	46	2.2k
Christophe Préhaud France	28	791 0.6×	752 0.8×	1.1k 1.1×	586 1.5×	297 0.8×	57	2.6k
Christine Tuffereau France	22	1.2k 0.8×	769 0.8×	461 0.5×	364 0.9×	377 1.0×	30	1.6k
Teshome Mebatsion Germany	20	840 0.6×	1.4k 1.4×	1.0k 1.0×	290 0.7×	478 1.3×	29	2.3k
F Lafay France	21	920 0.7×	816 0.8×	347 0.4×	333 0.8×	395 1.1×	36	1.6k
Christoph Wirblich United States	31	657 0.5×	773 0.8×	2.0k 2.0×	422 1.1×	412 1.1×	53	2.9k
Danielle Blondel France	37	1.8k 1.3×	1.6k 1.6×	1.6k 1.6×	1.2k 3.0×	701 1.9×	66	4.1k
C. A. Speer United States	30	585 0.4×	1.6k 1.6×	483 0.5×	454 1.2×	453 1.2×	100	4.9k
Maria‐Isabel Thoulouze France	21	656 0.5×	484 0.5×	440 0.4×	472 1.2×	271 0.7×	35	2.2k
Hans G. Heine Australia	24	445 0.3×	1.1k 1.1×	390 0.4×	404 1.0×	327 0.9×	48	1.7k
Amy B. Papaneri United States	17	606 0.4×	480 0.5×	592 0.6×	179 0.5×	117 0.3×	26	1.2k

Countries citing papers authored by James P. McGettigan

Since Specialization

Citations

This map shows the geographic impact of James P. McGettigan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James P. McGettigan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James P. McGettigan more than expected).

Fields of papers citing papers by James P. McGettigan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James P. McGettigan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James P. McGettigan. The network helps show where James P. McGettigan may publish in the future.

Co-authorship network of co-authors of James P. McGettigan

This figure shows the co-authorship network connecting the top 25 collaborators of James P. McGettigan. A scholar is included among the top collaborators of James P. McGettigan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James P. McGettigan. James P. McGettigan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

McGettigan, James P., et al.. (2019). Incorporating B cell activating factor (BAFF) into the membrane of rabies virus (RABV) particles improves the speed and magnitude of vaccine-induced antibody responses. PLoS neglected tropical diseases. 13(11). e0007800–e0007800. 13 indexed citations

LaBranche, Celia C., et al.. (2015). A Bivalent, Chimeric Rabies Virus Expressing Simian Immunodeficiency Virus Envelope Induces Multifunctional Antibody Responses. AIDS Research and Human Retroviruses. 31(11). 1126–1138. 7 indexed citations

Lytle, Andrew, et al.. (2014). Lymph Node but Not Intradermal Injection Site Macrophages Are Critical for Germinal Center Formation and Antibody Responses to Rabies Vaccination. Journal of Virology. 89(5). 2842–2848. 11 indexed citations

McGettigan, James P., et al.. (2014). Safety and serological response to a matrix gene-deleted rabies virus-based vaccine vector in dogs. Vaccine. 32(15). 1716–1719. 9 indexed citations

Lytle, Andrew, et al.. (2013). B Cell Infection and Activation by Rabies Virus-Based Vaccines. Journal of Virology. 87(16). 9097–9110. 18 indexed citations

Dorfmeier, Corin L., Evgeni P. Tzvetkov, Anthony Gatt, & James P. McGettigan. (2013). Investigating the Role for IL-21 in Rabies Virus Vaccine-induced Immunity. PLoS neglected tropical diseases. 7(3). e2129–e2129. 20 indexed citations

Gomme, Emily, et al.. (2010). Characterization of a Single-Cycle Rabies Virus-Based Vaccine Vector. Journal of Virology. 84(6). 2820–2831. 40 indexed citations

Aye, Pyone P., Amy B. Papaneri, Bapi Pahar, et al.. (2009). Rabies virus-based vaccines elicit neutralizing antibodies, poly-functional CD8+ T cell, and protect rhesus macaques from AIDS-like disease after SIVmac251 challenge. Vaccine. 28(2). 299–308. 30 indexed citations

Cenna, Jonathan, Meredith Hunter, Gene S. Tan, et al.. (2009). Replication‐Deficient Rabies Virus–Based Vaccines Are Safe and Immunogenic in Mice and Nonhuman Primates. The Journal of Infectious Diseases. 200(8). 1251–1260. 40 indexed citations

10.

Wanjalla, Celestine N., et al.. (2008). Interferon-β expressed by a rabies virus-based HIV-1 vaccine vector serves as a molecular adjuvant and decreases pathogenicity. Virology. 382(2). 226–238. 48 indexed citations

11.

Cenna, Jonathan, Gene S. Tan, Amy B. Papaneri, et al.. (2008). Immune modulating effect by a phosphoprotein-deleted rabies virus vaccine vector expressing two copies of the rabies virus glycoprotein gene. Vaccine. 26(50). 6405–6414. 43 indexed citations

12.

Li, Jianwei, James P. McGettigan, Milosz Faber, Matthias J. Schnell, & Bernhard Dietzschold. (2007). Infection of monocytes or immature dendritic cells (DCs) with an attenuated rabies virus results in DC maturation and a strong activation of the NFκB signaling pathway. Vaccine. 26(3). 419–426. 38 indexed citations

13.

Li, Jianwei, Milosz Faber, Amy B. Papaneri, et al.. (2006). A single immunization with a recombinant canine adenovirus expressing the rabies virus G protein confers protective immunity against rabies in mice. Virology. 356(1-2). 147–154. 37 indexed citations

14.

Dave, Rajnish S., et al.. (2006). siRNA targeting Vaccinia virus double-stranded RNA binding protein [E3L] exerts potent antiviral effects. Virology. 348(2). 489–497. 21 indexed citations

15.

Smith, Mary Ellen, Martin L. Koser, Sa Xiao, et al.. (2006). Rabies virus glycoprotein as a carrier for anthrax protective antigen. Virology. 353(2). 344–356. 34 indexed citations

16.

McGettigan, James P., Martin L. Koser, Philip M. McKenna, et al.. (2005). Enhanced humoral HIV-1-specifc immune responses generated from recombinant rhabdoviral-based vaccine vectors co-expressing HIV-1 proteins and IL-2. Virology. 344(2). 363–377. 25 indexed citations

17.

Faber, Milosz, Rojjanaporn Pulmanausahakul, Sergei Spitsin, et al.. (2002). Overexpression of the Rabies Virus Glycoprotein Results in Enhancement of Apoptosis and Antiviral Immune Response. Journal of Virology. 76(7). 3374–3381. 168 indexed citations

18.

Morimoto, Kanehisa, Matthias J. Schnell, Rojjanaporn Pulmanausahakul, et al.. (2001). High level expression of a human rabies virus-neutralizing monoclonal antibody by a rhabdovirus-based vector. Journal of Immunological Methods. 252(1-2). 199–206. 24 indexed citations

19.

Morimoto, Kinjiro, James P. McGettigan, H. Foley, et al.. (2001). Genetic engineering of live rabies vaccines. Vaccine. 19(25-26). 3543–3551. 56 indexed citations

20.

Morimoto, Kinjiro, H. Foley, James P. McGettigan, Matthias J. Schnell, & Bernhard Dietzschold. (2000). Reinvestigation of the role of the rabies virus glycoprotein in viral pathogenesis using a reverse genetics approach. Journal of NeuroVirology. 6(5). 373–381. 98 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact